ARTICLE | Clinical News
Cellectis preclinical data
July 22, 2013 7:00 AM UTC
Cellectis said UCART19 eradicated human leukemia cells that were transferred into mice. The company plans to start Phase I testing of the chimeric antigen receptor (CAR)-modified CD19-targeted allogen...